NRP2 and metastatic malignant neoplasm in the lymph nodes: Consequently, the objective of this study was to assess NRP2 and its ligand SEMA3F as potential biomarkers for patient survival and their ability to predict lymph node metastases in esophageal adenocarcinoma.